Welcome to our dedicated page for CHFW news (Ticker: CHFW), a resource for investors and traders seeking the latest updates and insights on CHFW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CHFW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CHFW's position in the market.
Surrozen, Inc. has completed its business combination with Consonance-HFW Acquisition Corp., a special purpose acquisition company. The merger was approved by shareholders on August 10, 2021, and will enable Surrozen to trade its shares on Nasdaq under the ticker symbol SRZN and its warrants as SRZNW beginning August 12, 2021. Surrozen aims to unlock therapeutic applications of the Wnt pathway for tissue repair and regeneration, with a management team led by CEO Craig Parker, focusing on developing innovative therapies for serious diseases.
Consonance-HFW Acquisition Corp. (NYSE American: CHFW) announced plans for its business combination with Surrozen, Inc. Following the domestication process, trading of New Surrozen Common Stock and Warrants will commence on Nasdaq under the symbols ‘SRZN’ and ‘SRZNW’ on August 12, 2021. Existing CHFW shareholders will see their shares automatically converted to New Surrozen shares without action required. The business combination is pending final shareholder approval on August 10, 2021, and is subject to customary closing conditions.
